People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

71.75CHF
8 Feb 2016
Change (% chg)

-- (--)
Prev Close
CHF71.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,172,452
52-wk High
CHF103.20
52-wk Low
CHF71.45

Search Stocks

Jimenez, Joseph 

Mr. Joseph S. Jimenez has been Chief Executive Officer and Member of the Executive Committee of Novartis AG since February 1, 2010. Prior to that, he served as CEO - Pharmaceuticals Division as of October 2007. In the Company he is responsible for heading the Company's diversified healthcare portfolio of innovative pharmaceuticals, generics, vaccines and diagnostics and consumer health products. Previously, Mr. Jimenez served as Division Head, Novartis Pharmaceuticals. Mr. Jimenez joined Novartis in April 2007 as Division Head, Novartis Consumer Health. Previously, he served as President and Chief Executive Officer (CEO) of the North America business for the H.J. Heinz Company and as President and CEO of Heinz in Europe from 2002 to 2006. Prior to joining Novartis, he was a Non-Executive Director of Astra-Zeneca plc, United Kingdom, from 2002 to 2007. He was also an advisor for the private equity organization Blackstone Group in the United States. Mr. Jimenez is Member of the Board of Directors of Colgate-Palmolive. He graduated with a bachelors degree from Stanford University in 1982 and with a Master of Business Administration (MBA) degree from the University of California, Berkeley, in 1984.

Basic Compensation

Total Annual Compensation, CHF 3,116,620
Restricted Stock Awards, CHF --
Long-Term Incentive Plans, CHF 9,839,950
All Other, CHF 269,723
Fiscal Year Total, CHF 13,226,300

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt

1,900,810

Joseph Jimenez

13,226,300

Ulrich Lehner

1,328,210

Harry Kirsch

2,344,290

Peter Kornicker

--

Felix Ehrat

4,321,510
As Of  30 Dec 2013
Search Stocks